Improving Informed Decision Making for Cancer Clinical Trial Participation

Educational Problems Clinical Trial

Official title:

Improving Informed Decision Making for Cancer Clinical Trial Participation

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03820687
• Other study ID #: HSC20180283H
• Status: Recruiting
• Phase: N/A
• Start date: February 8, 2023
• Est. completion date: December 31, 2026

Study information

• Verified date: December 2023
• Source: The University of Texas Health Science Center at San Antonio
• Contact: Vivian Cortez, MS
• Phone: 210-562-6546
• Email: cortezv1[@]uthscsa.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this study is to develop and pilot test a multi-communication approach to improve informed decision-making about cancer Clinical Trials (CTs) participation by increasing awareness of CTs and Mays Cancer Center (MCC) services (treatment care capacities, reputation and resources), positive attitudes towards CTs, self-efficacy and intentions to consider CTs as an appropriate treatment option for cancer (intention to participate) among patients attending the MCC (clinic-based setting) and the general public in selected Bexar County areas (community-based settings).

Description:

The proposed two-year study involves a randomized controlled educational trial featuring a 2-group parallel cohort design with random assignment of 400 cancer patients from the MCC to the intervention or usual care control group. Intervention participants will receive 3 components: 1) a bilingual culturally relevant educational video, 2) a low-literacy booklet and 3) support from a patient navigator to empower new cancer patients to make informed decisions about cancer CT participation by increasing awareness of clinical trials and MCC services, positive attitudes and intentions to consider CTs as an appropriate treatment option for cancer. The usual care control group will receive a general CT fact sheet.

The community setting will involve a community awareness campaign including 400 community members, with 3 components: 1) an educational session delivered via PowerPoint presentation or flip chart, 2) a low-literacy booklet, and 3) support from a community health educator to raise awareness, positive attitudes and intentions to consider CTs as an appropriate treatment option for cancer and promote the MCC services among community members in Bexar County.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 800
• Est. completion date: December 31, 2026
• Est. primary completion date: December 31, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Newly diagnosed cancer patients (within 1 year) attending any of the clinics at the MCC

• Patients who have not participated in a Clinical Trial before

• English or Spanish-speaking

• Able to provide informed consent

Exclusion Criteria:

• Younger than 18 years

• Patients who have already had a consultation with their doctor to discuss treatment options

• Patients who have participated in a Clinical Trial before

• Unable to provide informed consent

Related Conditions & MeSH terms

• Educational Problems

Intervention

Other:
• Clinical Trial Educational Video
Bilingual, culturally tailored educational video, low literacy booklet, and support from a patient navigator to empower new cancer patients to make informed decisions about cancer clinical trial participation.
• Clinical Trial Fact Sheet
General Clinical Trial fact sheet with usual care information regarding Clinical Trials.
• Low literacy booklet
A bilingual low-literacy booklet with educational content about clinical trials.
• Navigator
Support will be provided by a patient navigator to empower cancer patients to make an informed decision about cancer clinical trial participation by increasing awareness of clinical trials and MCC services, positive attitudes, and intentions to consider clinical trials as an appropriate treatment option for cancer.

Locations

Country	Name	City	State
United States	University of Texas Health Science Center San Antonio, MCC	San Antonio	Texas

Sponsors (2)

Lead Sponsor	Collaborator
The University of Texas Health Science Center at San Antonio	Genentech, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Proportion of patients who show intention to participate or to consider CTs as an appropriate treatment option for cancer.	The percentage of patients who increased intentions to participate in a CT after the intervention compared with baseline.	Up to 3 months after the index oncology visit
Secondary	Proportion of patients who show increase in knowledge/awareness regarding CT participation.	The percentage of patients who improved knowledge/awareness about clinical trials after the intervention compared with baseline.	Up to 3 months after the index oncology visit
Secondary	Proportion of patients who show improved attitudes regarding CT participation.	The percentage of patients who improve their attitudes towards clinical trial participation after the intervention compared with baseline.	Up to 3 months after the index oncology visit
Secondary	Proportion of patients eligible for designated clinical trials who actually enroll in one of these trials.	The percentage of patients who actually participate, or enroll in a clinical trial if they meet the eligibility criteria.	Up to 3 months after the index oncology visit